We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > meeting

News List

Hovione Announces Successful End-of-Phase 2 Meeting with the FDA americanpharmaceuticalreview
September 23, 2019
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
Motif Bio Announces Path Forward for Iclaprim following Receipt of FDA Meeting Minutes drugs
June 13, 2019
Motif Bio Announces Path Forward for Iclaprim following Receipt of FDA Meeting Minutes.
Roche Annual General Meeting 2017 worldpharmanews
March 15, 2017
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its shareholders approved all proposals of the Board of Directors at its ordinary Annual General Meeting (AGM).